Search | Page 7 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Allogeneic stem cell transplantation for myelodysplastic syndromes: critical for cure?

    ... cytogenetics , who have a histocompatible related or unrelated donor . For patients who lack an human leukocyte antigen -compatible ...

    Research Article last updated 11/16/2011 - 2:15pm.

  2. Aplastic anemia: pathophysiology and treatment.

    ... AA, whether from an HLA identical sibling or an unrelated donor , provides an excellent chance of long term cure. Current issues with ...

    Research Article last updated 10/11/2011 - 5:58pm.

  3. Alternative donor transplantation for aplastic anemia.

    ... have an adequate sustained response. Barriers to the use of unrelated-donor transplantation for aplastic anemia include identifying a ...

    Research Article last updated 10/11/2011 - 5:58pm.

  4. Therapy for aplastic anemia

    ... of 2 South American parents without any matches in the unrelated donor registry, including cord blood. He is red cell- and platelet ...

    Research Article last updated 01/09/2012 - 10:58am.

  5. Alternative donor HSCT in refractory acquired aplastic anemia - Prevention of graft rejection and graft versus host disease by immunoablative conditioning and graft manipulation

    ... S, Lackner H, Müller E, Schwinger W. Alternative donor HSCT in refractory acquired aplastic anemia - Prevention ... refractory AAA without a MSD underwent HSCT from matched unrelated (n = 6) or haploidentical (n = 1) donors. Conditioning ...

    Research Article last updated 07/30/2012 - 2:02pm.

  6. Jill Whitney – Since my diagnosis, my mission has been to fight back

    ... my only sibling was my half-brother, the search for an unrelated donor match began. At the time, our youngest daughter was 14, and Stanford ...

    Patient Chronicle last updated 05/26/2015 - 9:29am.

  7. Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials Network.

    ... should be developed; (4) innovative approaches to unrelated donor BMT that decrease graft-versus-host disease are needed; and (5) ...

    Research Article last updated 10/11/2011 - 5:58pm.

  8. Late Effects in Hematopoietic Cell Transplant Recipients with Acquired Severe Aplastic Anemia: A Report from the Late Effects Working Committee of the Center for International Blood and Marrow Transplant Research

    ... (68.5%) and 542 (31.5%) patients underwent a matched sibling donor (MSD) or unrelated donor (URD) HCT, respectively. The median age at the time of HCT ...

    Research Article last updated 10/01/2012 - 9:20am.

  9. Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant

    ... patients with hematologic malignancies undergoing unrelated donor peripheral blood stem cell transplant . Giving chemotherapy and total-body irradiation before a donor peripheral blood stem cell transplant (PBSCT) helps stop the growth of ...

    Clinical Trial last updated 04/28/2016 - 1:49pm.

  10. Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation

    ... the effect on grade II-IV GvHD when given after matched unrelated donor transplant (MUD). ...

    Clinical Trial last updated 05/02/2016 - 2:07pm.